rss
Br J Ophthalmol 2007;91:690-691 doi:10.1136/bjo.2006.097121
  • Letter

Cyclodiode treatment of neovascular glaucoma secondary to Coats’ disease

  1. D J de Silva,
  2. J L Brookes
  1. Moorfields Eye Hospital, London, UK
  1. Correspondence to: MrJ L Brookes Moorfields Eye Hospital, City Road, London EC1V 2PD, UK;john.brookes{at}moorfields.nhs.uk
  • Accepted 27 October 2006

Coats’ disease is characterised by an idiopathic retinal telangiectasia and exudative retinopathy, which may lead to retinal detachment.1–3 In 10% of eyes, neovascular glaucoma may occur and these eyes have been treated with primary enucleation.2,4 Although enucleation is an effective means of relieving severe ocular pain, it may remove an eye with some visual potential and postoperative complications occur in approximately 50% of cases.5,6 We report the first use of cyclodiode laser treatment in three consecutive patients with neovascular glaucoma secondary to advanced Coats’ disease.

Method

Three patients with neovascular glaucoma secondary to Coats’ disease presented to the Glaucoma Service at Moorfields Eye Hospital, London, UK, between 2004 and 2005. Table 1 summarises the characteristics of …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
 This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.